Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.67 USD | +1.29% | +3.74% | +0.08% |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- This company will be of major interest to investors in search of a high dividend stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- With an expected P/E ratio at 33.76 and 29.26 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.08% | 693M | C | ||
+5.55% | 55.76B | A- | ||
-10.37% | 17.72B | A- | ||
-3.21% | 13.23B | A | ||
+0.64% | 7.68B | B | ||
-17.93% | 5.39B | B- | ||
+9.90% | 3.28B | C- | ||
-0.80% | 3.23B | C+ | ||
-3.38% | 3.06B | B+ | ||
-3.56% | 2.73B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CHCT Stock
- Ratings Community Healthcare Trust Incorporated